220 related articles for article (PubMed ID: 30617471)
1. Long-term survival outcomes in invasive lobular carcinoma patients with and without preoperative MR imaging: a matched cohort study.
Ha SM; Chae EY; Cha JH; Kim HH; Shin HJ; Choi WJ
Eur Radiol; 2019 May; 29(5):2526-2534. PubMed ID: 30617471
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Survival Differences Between T1-2 Invasive Lobular Breast Cancer and Corresponding Ductal Carcinoma After Breast-Conserving Surgery: A Propensity-Scored Matched Longitudinal Cohort Study.
Wang K; Zhu GQ; Shi Y; Li ZY; Zhang X; Li HY
Clin Breast Cancer; 2019 Feb; 19(1):e101-e115. PubMed ID: 30502219
[TBL] [Abstract][Full Text] [Related]
3. Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival.
García-Fernández A; Lain JM; Chabrera C; García Font M; Fraile M; Barco I; Torras M; Reñe A; González S; González C; Piqueras M; Veloso E; Cirera L; Pessarrodona A; Giménez N
Breast J; 2015; 21(5):533-7. PubMed ID: 26190560
[TBL] [Abstract][Full Text] [Related]
4. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
[TBL] [Abstract][Full Text] [Related]
5. The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients.
Korhonen T; Kuukasjärvi T; Huhtala H; Alarmo EL; Holli K; Kallioniemi A; Pylkkänen L
Breast; 2013 Dec; 22(6):1119-24. PubMed ID: 23863867
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
[TBL] [Abstract][Full Text] [Related]
7. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
Sinha PS; Bendall S; Bates T
Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
[TBL] [Abstract][Full Text] [Related]
8. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
[TBL] [Abstract][Full Text] [Related]
9. Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
Wang T; Ma Y; Wang L; Liu H; Chen M; Niu R
Tumour Biol; 2015 Aug; 36(8):6113-24. PubMed ID: 25804795
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of lobular breast cancer histology: new insights from a single hospital cross-sectional study and SEER data.
Brouckaert O; Laenen A; Smeets A; Christiaens MR; Vergote I; Wildiers H; Moerman P; Floris G; Neven P;
Breast; 2014 Aug; 23(4):371-7. PubMed ID: 24530094
[TBL] [Abstract][Full Text] [Related]
11. Association of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancer.
Van Baelen K; Nguyen HL; Hamy-Petit AS; Richard F; Karsten MM; Nader Marta G; Vermeulen P; Toussaint A; Reyal F; Vincent-Salomon A; Dirix L; Dordevic AD; de Azambuja E; Larsimont D; Amato O; Maetens M; De Schepper M; Geukens T; Han SN; Baert T; Punie K; Wildiers H; Smeets A; Nevelsteen I; Floris G; Biganzoli E; Neven P; Desmedt C
Eur J Cancer; 2023 Sep; 191():112988. PubMed ID: 37573673
[TBL] [Abstract][Full Text] [Related]
12. Breast MRI in Invasive Lobular Carcinoma: A Useful Investigation in Surgical Planning?
Parvaiz MA; Yang P; Razia E; Mascarenhas M; Deacon C; Matey P; Isgar B; Sircar T
Breast J; 2016; 22(2):143-50. PubMed ID: 26841281
[TBL] [Abstract][Full Text] [Related]
13. Location of Receipt of Initial Treatment and Outcomes in Long-Term Breast Cancer Survivors.
Sinha AK; Patel JR; Shen Y; Ueno NT; Giordano SH; Tripathy D; Lopez DS; Barcenas CH
PLoS One; 2017; 12(1):e0170081. PubMed ID: 28085940
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma.
Shah C; Wilkinson JB; Shaitelman S; Grills I; Wallace M; Mitchell C; Vicini F
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e547-51. PubMed ID: 21640491
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy.
Hwang N; Schiller DE; Crystal P; Maki E; McCready DR
Ann Surg Oncol; 2009 Nov; 16(11):3000-9. PubMed ID: 19603233
[TBL] [Abstract][Full Text] [Related]
16. Impact of invasive lobular carcinoma on long-term outcomes in Mexican breast cancer patients.
Flores-Díaz D; Arce C; Flores-Luna L; Reynoso-Noveron N; Lara-Medina F; Matus JA; Bargallo-Rocha E; Pérez V; Villarreal-Garza C; Cabrera-Galeana P; Mohar A
Breast Cancer Res Treat; 2019 Jul; 176(1):243-249. PubMed ID: 30997623
[TBL] [Abstract][Full Text] [Related]
17. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.
Inoue M; Nakagomi H; Nakada H; Furuya K; Ikegame K; Watanabe H; Omata M; Oyama T
Breast Cancer; 2017 Sep; 24(5):667-672. PubMed ID: 28108967
[TBL] [Abstract][Full Text] [Related]
18. Postmastectomy Radiation Therapy Is Associated With Improved Survival in Node-Positive Male Breast Cancer: A Population Analysis.
Abrams MJ; Koffer PP; Wazer DE; Hepel JT
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):384-391. PubMed ID: 28463158
[TBL] [Abstract][Full Text] [Related]
19. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology.
Moran MS; Yang Q; Haffty BG
Breast J; 2009; 15(6):571-8. PubMed ID: 19995377
[TBL] [Abstract][Full Text] [Related]
20. Tumor characteristics and the clinical outcome of invasive lobular carcinoma compared to infiltrating ductal carcinoma in a Chinese population.
Cao AY; Huang L; Wu J; Lu JS; Liu GY; Shen ZZ; Shao ZM; Di GH
World J Surg Oncol; 2012 Jul; 10():152. PubMed ID: 22805492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
